Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of the Duration of Glucagon’s Waning Effect on Hepatic Glucose Production in Type 1 Diabetes
2015-000322-11Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of glucagon in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoint: ΔAUCHGP. Started Feb 2015; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-000322-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000322-11.